Literature DB >> 711612

Action of cefoxitin and cefamandole on human neutrophil function.

J A Majeski, M J Morris, J W Alexander.   

Abstract

Polymorphonuclear neutrophilic leukocyte chemotaxis was examined in vitro in the presence to two new antibiotics: cefamandole and cefoxitin. Results indicate that cefamandole inhibited neutrophil chemotaxis to a significant degree only at high antibiotic concentrations of 100 microgram/ml (P less than 0.01) and has no significant effect at normal serum therapeutic range. Cefoxitin was found to produce a 43% inhibition (P less than 0.01) of human in vivo neutrophil chemotaxis at antibiotic concentrations of 100 microgram/ml and have a minimal inhibitory effect (1 approximately 9%) at low concentrations (1 approximately 5 microgram/ml). Both cefamandole and cefoxitin had no significant effect on opsonophagocytosis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 711612     DOI: 10.7164/antibiotics.31.1059

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  4 in total

1.  Comparative effects of moxalactam and gentamicin on human polymorphonuclear leukocyte functions.

Authors:  C Burgaleta; J Martínez-Beltrán; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

2.  Interaction of beta-lactam antibiotics with the bactericidal activity of leukocytes against Escherichia coli.

Authors:  A Dalhoff
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

3.  Stimulation of granulocyte functions in vitro by imipenem and the renal enzyme inhibitor MK 0791.

Authors:  H Gnarpe; J Belsheim; C Blomqvist; A Lundbäck
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

4.  Effect of antimicrobial agents on human polymorphonuclear leukocyte microbicidal function.

Authors:  W D Welch; D Davis; L D Thrupp
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.